Literature DB >> 24803796

Inflammatory bowel disease and celiac disease: overlaps and differences.

Virginia Pascual1, Romina Dieli-Crimi1, Natalia López-Palacios1, Andrés Bodas1, Luz María Medrano1, Concepción Núñez1.   

Abstract

Recent findings demonstrate the common genetic basis for many immune-mediated diseases, and consequently, the partially shared pathogenesis. We collected these findings and reviewed the extension of these overlaps to other disease characteristics. Two autoimmune diseases were selected that also share the specific target organ, the bowel. The etiology and immunopathogenesis of both conditions characterized by chronic intestinal inflammation, inflammatory bowel disease (IBD) and celiac disease (CeD), are not completely understood. Both are complex diseases with genetics and environment contributing to dysregulation of innate and adaptive immune responses, leading to chronic inflammation and disease. CeD constitutes a particular disease because the main environmental and genetic triggers are largely known. IBD comprises two main clinical forms, Crohn's disease and ulcerative colitis, which most likely involve a complex interplay between some components of the commensal microbiota and other environmental factors in their origin. These multifactorial diseases encompass a broad spectrum of clinical phenotypes and ages of onset, although the clinical presentation often differs depending on childhood or adult onset, with greater heterogeneity commonly observed in adults.

Entities:  

Keywords:  Disease susceptibility; Gene-environment interaction; Immune system; Inflammation; Inflammatory bowel disease; Microbiota

Mesh:

Substances:

Year:  2014        PMID: 24803796      PMCID: PMC4009516          DOI: 10.3748/wjg.v20.i17.4846

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  88 in total

1.  Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.

Authors:  Klaus R Herrlinger; Thomas Witthoeft; Andreas Raedler; Bernd Bokemeyer; Thomas Krummenerl; Jorg-Dieter Schulzke; Norbert Boerner; Bruno Kueppers; Joerg Emmrich; Axel Mescheder; Ulrich Schwertschlag; Mark Shapiro; Eduard F Stange
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

2.  Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn´s disease and autoimmune diabetes.

Authors:  Virgínia Lúcia Ribeiro-Cabral; Francy Reis da-Silva-Patrício; Orlando Ambrogini-Junior; Sender Jankiel-Miszputen
Journal:  Rev Esp Enferm Dig       Date:  2011-09       Impact factor: 2.086

3.  The management of complicated celiac disease.

Authors:  A Al-toma; W H M Verbeek; C J J Mulder
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

4.  Familial association of Crohn's and coeliac diseases.

Authors:  M Cottone; M Cappello; A Puleo; C Cipolla; M G Filippazzo
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

5.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

Authors: 
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

6.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

7.  High prevalence of celiac disease among patients affected by Crohn's disease.

Authors:  Antonio Tursi; Gian Marco Giorgetti; Giovanni Brandimarte; Walter Elisei
Journal:  Inflamm Bowel Dis       Date:  2005-07       Impact factor: 5.325

8.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

9.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 10.  Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice.

Authors:  Jacques Cosnes
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-06       Impact factor: 3.043

View more
  25 in total

1.  Incidence of IBD Among Immigrants to Canada and Their Children: Could Gluten Consumption and Celiac Disease Partly Explain the Variation?

Authors:  Esme R Fuller-Thomson
Journal:  Am J Gastroenterol       Date:  2015-09       Impact factor: 10.864

2.  Response to Fuller-Thomson.

Authors:  Eric I Benchimol; David R Mack; Geoffrey C Nguyen
Journal:  Am J Gastroenterol       Date:  2015-09       Impact factor: 10.864

3.  Ex vivo immunomodulatory effect of ethanolic extract of propolis during Celiac Disease: involvement of nitric oxide pathway.

Authors:  Oussama Medjeber; Kahina Touri; Hayet Rafa; Zineb Djeraba; Mourad Belkhelfa; Amira Fatima Boutaleb; Amina Arroul-Lammali; Houda Belguendouz; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-07       Impact factor: 4.473

4.  Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.

Authors:  John Gubatan; George Triadafilopoulos; Nielsen Q Fernandez-Becker
Journal:  Dig Dis Sci       Date:  2020-04       Impact factor: 3.199

Review 5.  Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches.

Authors:  Sajid Ur Rahman; Yu Li; Yingying Huang; Lei Zhu; Shibin Feng; Jinjie Wu; Xichun Wang
Journal:  Inflammopharmacology       Date:  2018-03-12       Impact factor: 4.473

6.  A possible role for ghrelin, leptin, brain-derived neurotrophic factor and docosahexaenoic acid in reducing the quality of life of coeliac disease patients following a gluten-free diet.

Authors:  Francesco Russo; Guglielmina Chimienti; Caterina Clemente; Carla Ferreri; Antonella Orlando; Giuseppe Riezzo
Journal:  Eur J Nutr       Date:  2015-12-21       Impact factor: 5.614

7.  Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Authors:  Michał Łodyga; Piotr Eder; Magdalena Gawron-Kiszka; Agnieszka Dobrowolska; Maciej Gonciarz; Marek Hartleb; Maria Kłopocka; Ewa Małecka-Wojciesko; Piotr Radwan; Jarosław Reguła; Edyta Zagórowicz; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-11-19

8.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

9.  Causal Estimation with Functional Confounders.

Authors:  Aahlad Puli; Adler J Perotte; Rajesh Ranganath
Journal:  Adv Neural Inf Process Syst       Date:  2020-12

10.  The expression levels of CHI3L1 and IL15Rα correlate with TGM2 in duodenum biopsies of patients with celiac disease.

Authors:  Paola Catrogiovanni; Giuseppe Musumeci; Salvatore Giunta; Rosa Imbesi; Michelino Di Rosa
Journal:  Inflamm Res       Date:  2020-06-04       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.